Additionally, our clinical data showed that low-level of miR-214 and CDH1 and high-level of EZH2 and CTNNB1 were significantly associated with early recurrent HCC disease and can be predictors of comparatively reduction in disease-free survival (Fig. 7). This evidence concerns the gene EZH2 and hepatocellular carcinoma.